Originally from the Bahamas, Dr. Glass enrolled in the Medical Scientist Training Program at Baylor College of Medicine (BCM) in 1998. He received his PhD from BCM in 2005 from the Department of Human Genetics where he studied the role of Canonical Wnt Signaling in Bone Regulation. He received his MD from BCM in 2006 and compleed his transitional year internship at Cambridge Hospital in Massachusetts in 2008. Dr. Glass completed his residency training in Dermatology and a postdoctoral fellowship in the McDermott Center (with Helen Hobbs) at the University of Texas Southwestern Medical Center.  He is board certified by the American Board of Dermatology.

Dr. Glass' main research interest is in understanding how keloids (exuberant scarring of the skin) occur and in finding the genes that predispose people to develop keloids. Keloids occur disproportionately more often in skin of color, and the ability to develop keloids can be inherited within families. Dr. Glass is compiling a registry of individuals as well as families affected by keloids in order to collect samples and information to study keloids further. His other research interest is identifying genes that cause rare skin disorders. Dr. Glass practices general dermatology and has an interest in genetic skin disorders.


Medical School
Baylor College of Medicine (2006)
Cambridge Hospital (2008), Transitional Year
UT Southwestern Medical Center (2011), Dermatology

Research Interest

  • Dermal Biology
  • Fibroblasts
  • Genetics
  • Keloids


Featured Publications LegendFeatured Publications

Widespread Eruption of Comedones.
Kailas A, Vandergriff T, Glass DA Am J Dermatopathol 2017 Dec
Barber Knowledge and Recommendations Regarding Pseudofolliculitis Barbae and Acne Keloidalis Nuchae in an Urban Setting.
Adotama P, Tinker D, Mitchell K, Glass DA, Allen P JAMA Dermatol 2017 Oct
Dermatology in Orbit: Anticipating Skincare Requirements in the Space Age.
Rutherford A, Glass DA, Savory S J. Am. Acad. Dermatol. 2017 Sep
Prescription-level factors associated with primary nonadherence to dermatologic medications.
Rutherford A, Glass DA, Suarez EA, Adamson AS J Dermatolog Treat 2017 Aug 1-5
Patient-provider race and sex concordance and the risk for medication primary nonadherence.
Adamson AS, Glass DA, Suarez EA J. Am. Acad. Dermatol. 2017 Jun 76 6 1193-1195
Osteoclast-Like Giant Cells in Malignant Melanoma: Unintentional Accident or Strategic Recruitment?
Li X, Savory S, Vandergriff T, Glass DA Am J Dermatopathol 2017 May
Multiple Tumors on the Extremities.
Ukoha UT, Vandergriff T, Cheng J, Glass DA Am J Dermatopathol 2017 Apr
A Novel Homozygous Missense Mutation in HOXC13 Leads to Autosomal Recessive Pure Hair and Nail Ectodermal Dysplasia.
Li X, Orseth ML, Smith JM, Brehm MA, Agim NG, Glass DA Pediatr Dermatol 2017 Mar 34 2 172-175
Systemic lupus erythematosus in a patient with PTEN hamartoma tumour syndrome.
Lee T, Le EN, Glass DA, Bowen CD, Dominguez AR Br. J. Dermatol. 2014 Apr 170 4 990-2
Primary milia localized to the vulva.
Adotama P, Susa J, Glass DA Dermatol. Online J. 2014 20 4 22339


Featured Books Legend Featured Books

Honors & Awards

  • Children's Medical Center CCRAC
    Junior Investigator Research Award (2013)
  • Dermatology Foundation
    Career Development Award (2013)
  • UT-Southwestern / Galderma
    Pilot & Feasibility Study Grant (2012)
  • Dermatology Foundation
    Dermatologist Investigator Research Fellowship Award (2011)
  • Skin of Color Society
    AMBI Research Grant (2011)
  • UT-Southwestern Medical Center
    Physcian Scientist Training Program (2010)
  • BCM Outstanding Student Award
    Graduate School (2006)
  • Graduate Student Rep Speaker
    BCM Commencement (2006)
  • Speaker, Gordon Research Conference
    Bones and Teeth (2005)

Professional Associations/Affiliations

  • American Academy of Dermatology
  • Dallas County Medical Society
  • Dermatology Foundation
  • National Medical Association
  • Skin of Color Society
  • Society for Investigative Dermatology
  • Texas Medical Association
  • Women's Dermatologic Society